Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CNB Financial | CCNE | Oct 31, 2024 | 25.38 | -1.63 |
CNB Financial Pref | CCNEP | Oct 31, 2024 | 24.20 | -0.82 |
CNFinance ADR | CNF | Oct 31, 2024 | 1.07 | -6.96 |
CNH Industrial N.V. | CNH | Oct 31, 2024 | 11.23 | -0.27 |
CNO Financial Group | CNO | Oct 31, 2024 | 34.40 | -1.88 |
CNS Pharmaceuticals | CNSP | Oct 31, 2024 | 0.11 | -8.15 |
CNX Resources | CNX | Oct 31, 2024 | 34.03 | -3.08 |
Co-Diagnostics | CODX | Oct 31, 2024 | 1.21 | -0.82 |
Coastal Financial | CCB | Oct 31, 2024 | 62.99 | -5.38 |
Coca-Cola | KO | Oct 31, 2024 | 65.31 | -0.93 |
Coca-Cola Consolidated | COKE | Oct 31, 2024 | 1 124.26 | -6.28 |
Coca-Cola Europacific Partners | CCEP | Oct 31, 2024 | 76.00 | -0.52 |
Coca-Cola FEMSA ADR | KOF | Oct 31, 2024 | 83.37 | -1.83 |
Cocrystal Pharma | COCP | Oct 31, 2024 | 1.77 | -2.21 |
Coda Octopus | CODA | Oct 31, 2024 | 8.53 | -1.50 |
Codere Online Luxembourg | CDRO | Oct 31, 2024 | 7.86 | -0.63 |
Codexis | CDXS | Oct 31, 2024 | 3.14 | -2.18 |
Coeptis Therapeutics | COEP | Oct 31, 2024 | 0.20 | -4.26 |
Coeur Mining | CDE | Oct 31, 2024 | 6.44 | -5.57 |
Coffee Holding Company | JVA | Oct 31, 2024 | 3.03 | -1.94 |
Cogent Biosciences | COGT | Oct 31, 2024 | 11.49 | -4.33 |
Cogent Communications | CCOI | Oct 31, 2024 | 80.27 | -1.62 |
Cognex | CGNX | Oct 31, 2024 | 40.23 | -0.57 |
Cognition Therapeutics | CGTX | Oct 31, 2024 | 0.47 | -11.09 |
Cognizant Technology Solutions A | CTSH | Oct 31, 2024 | 74.59 | +0.32 |
Cognyte Software | CGNT | Oct 31, 2024 | 6.49 | -1.52 |
Cohen & Company | COHN | Oct 31, 2024 | 8.38 | -0.10 |
Cohen & Steers | CNS | Oct 31, 2024 | 98.77 | -2.17 |
Cohen & Steers Closedend Opportunity Fund | FOF | Oct 31, 2024 | 12.77 | -0.55 |
Cohen & Steers Duration Pref and Income Fund | LDP | Oct 31, 2024 | 20.92 | -0.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.